Join Us

We are 224,253 members in 83 forums discussing 163,465 topics.

Help with Abbreviations

Topic: Breaking Research News from Breastcancer.org

Forum: Clinical Trials, Research News, Podcasts, and Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Apr 16, 2012 09:33AM - edited Jan 16, 2016 11:28AM by Moderators

Moderators wrote:

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Check out this thread on a regular basis to see all the breaking news about current breast cancer research from our experts.

Get Personalized Research News Stories JUST for You!
Don't forget to fill out your profile: In the top right hand corner of the screen, under My Profile, you'll find My Diagnoses and My Treatments. Once you've provided enough information, we'll send recommended articles. Members can save these articles for later, or archive them when they're finished with them.

If you would like to receive Personalized Research News articles, based on diagnosis and treatment information, you'll need to go into "My Profile" and under the "Recommended Articles", click "turn on".

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 40 of 40 (1,199 results)

Posts 1171 - 1199 (1,199 total)

Log in to post a reply

Jul 2, 2021 08:31AM Moderators wrote:

More Abdominal Fat Linked to Worse Outcomes for Black Women Who Are Breast Cancer Survivors
June 29, 2021

Black women diagnosed with breast cancer who also have central obesity — excess body fat in the abdominal area — were more likely to die from breast cancer or any other cause than similar women who didn't have central obesity. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 2, 2021 08:32AM Moderators wrote:

Poor Quality of Life Linked to Stopping Hormonal Therapy Treatment Early
July 1, 2021

Women who report worse quality of life factors, such as poor physical well-being, poor social well-being, and a history of depression, are more likely to stop hormonal therapy early. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 8, 2021 11:02AM Moderators wrote:

Women With BRCA1 Gene Mutation Have Fewer Eggs in Ovaries
July 1, 2021

Women with a mutation in the BRCA1 gene likely have fewer eggs in their ovaries than the average woman, which may shorten their window of opportunity to have children. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 8, 2021 11:03AM Moderators wrote:

Study Finds No Link Between Fertility Treatments and Breast Cancer Risk
July 1, 2021

Medicines commonly used to stimulate the ovaries to release eggs during fertility treatment don't seem to increase the risk of developing breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 8, 2021 11:04AM Moderators wrote:

More Than 2 Years of Bisphosphonates for Early-Stage Breast Cancer Doesn't Offer More Benefits
July 2, 2021

Receiving 3 to 5 years of bisphosphonate treatment after surgery and chemotherapy for early-stage breast cancer doesn't improve survival any more than receiving 2 years of bisphosphonate treatment. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 8, 2021 11:05AM Moderators wrote:

Chemotherapy for Breast Cancer Doesn't Seem To Increase Risk of COVID-19 Infection or Death
July 7, 2021

Women treated with chemotherapy for breast cancer were no more likely to be infected with COVID-19 or die from COVID-19 than women treated with other medicines that don't weaken the immune system. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 13, 2021 12:34PM Moderators wrote:

Breast Cancer Death Rate Decreases in Florida, but Still Highest for Black Women
July 8, 2021

Breast cancer death rates decreased among all racial and ethnic groups from 1990 to 2015 in Florida, but Black women were still twice as likely to die from breast cancer as white women. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 29, 2021 12:04PM Moderators wrote:

Breast Cancer Screening Declined Sharply When Pandemic Started
July 23, 2021

A new study by the Centers for Disease Control and Prevention echoes the results of other studies: Breast cancer screening rates dropped dramatically at the beginning of the COVID-19 pandemic, especially among women of certain racial and ethnic groups. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 29, 2021 12:05PM Moderators wrote:

FDA Approves Keytruda for Early-Stage Triple-Negative Breast Cancer
July 27, 2021

The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 29, 2021 12:07PM Moderators wrote:

Keytruda Before and After Surgery Improves Outcomes in Early-Stage Triple-Negative Breast Cancer
July 27, 2021

The immunotherapy medicine Keytruda plus chemotherapy before surgery and Keytruda alone after surgery improved event-free survival better than chemotherapy alone in women diagnosed with early-stage triple-negative breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Aug 12, 2021 10:05AM Moderators wrote:

Guidelines Help Oncologists Provide Individualized Palliative Care for People Diagnosed With Metastatic Breast Cancer
August 3, 2021

General oncologists have received new specific, practical recommendations on how to offer individualized palliative care to people diagnosed with metastatic breast cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Aug 12, 2021 10:06AM Moderators wrote:

After 5 Years of Hormonal Therapy, 2 More Years of Arimidex Offers Same Benefits As 5 More Years for Postmenopausal Women With Early-Stage Breast Cancer
August 6, 2021

After taking 5 years of hormonal therapy following surgery, postmenopausal women diagnosed with early-stage hormone-receptor-positive breast cancer got the same benefits from taking 2 more years of Arimidex as they did from taking 5 more years, with fewer side effects. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Aug 13, 2021 09:26AM MinusTwo wrote:

Mods - Palliative Care guidelines are really important. Thanks for posting.

2/15/11 BMX-DCIS 2SNB clear-TEs; 9/15/11-410gummies; 3/20/13 recurrance-5.5cm,mets to lymphs, Stage IIIB IDC ER/PRneg,HER2+; TCH/Perjeta/Neulasta x6; ALND 9/24/13 1/18 nodes 4.5cm; AC chemo 10/30/13 x3; herceptin again; Rads Feb2014
Log in to post a reply

Aug 27, 2021 08:55AM Moderators wrote:

Treatment Break From Extended Femara Doesn't Affect Survival
August 17, 2021

Survival rates were the same in postmenopausal women diagnosed with early-stage hormone-receptor-positive breast cancer whether they took a short treatment break during extended adjuvant hormonal therapy with Femara or took Femara continuously for 5 years after previously taking hormonal therapy for an initial 5 years. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 1, 2021 09:51AM Moderators wrote:

Genentech Withdraws Breast Cancer Indication From Tecentriq
August 28, 2021

On Aug. 27, 2021, Genentech announced it is voluntarily withdrawing the breast cancer indication from the immunotherapy medicine Tecentriq in the United States. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 8, 2021 10:51AM Moderators wrote:

Chemo Brain Less Likely in Women Who Exercise
August 31, 2021

Women diagnosed with breast cancer who exercised before, during, and after chemotherapy were less likely to have chemo brain. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 17, 2021 09:16AM Moderators wrote:

Women With Breast Cancer Gene Mutation Have Same or Better Survival as Women Without Mutation
September 8, 2021

Women with a genetic mutation linked to a higher cancer risk who are diagnosed with breast cancer or ovarian cancer and receive chemotherapy treatment have the same or better survival rates as women who don't have a genetic mutation linked to higher risk. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 17, 2021 09:17AM Moderators wrote:

Six Months After Second Pfizer Vaccine Dose, People With Solid Tumors Have Same COVID-19 Antibody Levels as People Without Cancer
September 9, 2021

Six months after receiving their second dose of the Pfizer COVID-19 vaccine, people diagnosed with solid tumor cancers had about the same antibody levels as people who hadn't been diagnosed with cancer. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 22, 2021 09:53AM Moderators wrote:

Adding Surgery to Treatment Plan Offers Better Survival for Certain Women Diagnosed With Stage IV Breast Cancer
September 20, 2021

A combination of surgery and systemic therapy can improve survival more than systemic therapy alone for women diagnosed with stage IV breast cancer with known hormone receptor and HER2 status. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 22, 2021 09:53AM Moderators wrote:

Supervised Exercise Safe for People With Bone Metastases
September 20, 2021

People diagnosed with metastatic cancer that has spread to the bones can safely participate in supervised exercise programs, according to a review of 17 studies. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 22, 2021 09:54AM Moderators wrote:

Adding Carboplatin to Chemotherapy Before Surgery Improves Early-Stage Triple-Negative Breast Cancer Outcomes
September 20, 2021

Adding carboplatin (brand name: Paraplatin) to the standard neoadjuvant chemotherapy regimen for early-stage triple-negative breast cancer improved event-free survival. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 22, 2021 02:25PM Moderators wrote:

Enhertu Dramatically More Effective Than Kadcyla as Second Treatment for Metastatic HER2-Positive Breast Cancer
September 22, 2021

Enhertu more than doubled the 12-month progression-free survival rate than Kadcyla in people diagnosed with metastatic HER2-positive breast cancer that had been previously treated. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 6, 2021 01:18PM Moderators wrote:

After 2-3 Years of Tamoxifen, 5 Years of Femara Offers More Benefits Than 2-3 Years
September 30, 2021

After taking tamoxifen for 2 to 3 years following surgery, postmenopausal women diagnosed with early-stage hormone-receptor-positive breast cancer had a better survival rate from taking 5 years of Femara rather than 2 to 3 years of Femara. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 6, 2021 01:19PM Moderators wrote:

Adding Kisqali to Femara Improves Overall Survival for Postmenopausal Women With Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer
October 5, 2021

Adding Kisqali to Femara as a first treatment for advanced-stage hormone-receptor-positive HER2-negative breast cancer in postmenopausal women improved overall survival by more than 1 year. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 6, 2021 01:21PM Moderators wrote:

Experimental Vic-Trastuzumab Duocarmazine Better Than Doctors' Treatment Choices for Pre-treated Advanced-Stage HER2-Positive Breast Cancer
October 5, 2021

The experimental targeted therapy medicine vic-trastuzumab duocarmazine improved progression-free survival and overall survival more than doctors' treatment choice for people diagnosed with advanced-stage HER2-positive breast cancer that had been previously treated with anti-HER2 medicine. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 9, 2021 10:10AM Moderators wrote:

Adding Keytruda to Chemotherapy Improves Overall Survival in Metastatic, Strongly PD-L1-Positive Triple-Negative Breast Cancer
October 5, 2021

Adding the immunotherapy medicine Keytruda to chemotherapy improved overall survival more than chemotherapy alone in people diagnosed with metastatic triple-negative, strongly PD-L1-positive breast cancer, according to the KEYNOTE-355 study's final results. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Oct 9, 2021 10:11AM Moderators wrote:

Long-Term Side Effects Reduce Quality of Life Years After Cancer Diagnosis
October 5, 2021

About 4 years after being diagnosed with cancer, 14% of disease-free survivors were dissatisfied with the care they received for ongoing, long-term side effects of cancer treatment. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

17 hours ago Moderators wrote:

Risk of Triple-Negative Breast Cancer Nearly Three Times Higher for Black Women Than for White Women
October 12, 2021

Black women are 2.7 times more likely to be diagnosed with triple-negative breast cancer than white women, according to a study of risk factors in more than 198,000 women. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

17 hours ago - edited 16 hours ago by Moderators

Verzenio Approved To Treat Hormone-Receptor-Positive Early-Stage Breast Cancer With High Risk of Recurrence
October 13, 2021

The FDA approved Verzenio in combination with either tamoxifen or an aromatase inhibitor after surgery to treat early-stage hormone-receptor-positive HER2-negative node-positive breast cancer with high recurrence risk and a Ki-67 score of 20% or greater. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...

Page 40 of 40 (1,199 results)